ReviewDermatologic clinics2011
Diagnosis and clinical features of pemphigus foliaceus.
Review in Dermatologic clinics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 134 citations in OpenAlex.
- Efficacy and tolerability of rituximab in patients with pemphigus foliaceus: a single-centre retrospective cohort study.Skin health and disease · 2026Article
- When Neurodevelopment Meets Autoimmunity: Pemphigus Foliaceus in Rett Syndrome Expands the Clinical Spectrum-A Case Report.International journal of molecular sciences · 2026Article
- Article
- Impact of Poor Adherence to Treatment on Recurrent Disease Activity in Pemphigus Foliaceus: A Case Report.Cureus · 2026Article
- A diagnostically challenging case of pemphigus foliaceus without histologic evidence of acantholysis.Dermatology online journal · 2026Article
- Localized nasal dermatosis in a healthy male.JAAD case reports · 2026Article
- Article
- From Multiple Sclerosis to Organ-Specific Autoimmune Disorders: Insights into the Molecular and Clinical Implications of Comorbidity.Molecular neurobiology · 2025Review
- Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study.Dermatology practical & conceptual · 2025Article
- Focus on pemphigus treatment publications: A bibliometric and visual analysis (1992-2022).Heliyon · 2024Review
- Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker.Pathogens (Basel, Switzerland) · 2023Review
- New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.Clinical case reports · 2022Article
- Diagnostics of autoimmune blistering disorders: an experience of a single tertiary referral centre.Postepy dermatologii i alergologii · 2022Review
- Spongiotic Pattern in Pemphigus: A Retrospective Observational Single-Center Study.Dermatopathology (Basel, Switzerland) · 2022Article
- Vesiculobullous Diseases.Medicina (Kaunas, Lithuania) · 2022Article
- Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.Drug design, development and therapy · 2022Review
- Diagnosis of Generalized Pustular Psoriasis.American journal of clinical dermatology · 2022Review
- Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (Review).Experimental and therapeutic medicine · 2021Review
- Pemphigus-The Crux of Clinics, Research, and Treatment during the COVID-19 Pandemic.Biomedicines · 2021Review
- An Updated Review of Pemphigus Diseases.Medicina (Kaunas, Lithuania) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Pemphigus foliaceus is an acquired autoimmune blistering disease in which the body's immune system produces IgG autoantibodies that target the intercellular adhesion glycoprotein desmoglein-1, which is principally expressed in the granular layer of the epidermis, resulting in the loss of intercellular connections between keratinocytes (acantholysis) and the formation of subcorneal blisters within the epidermis. This article summarizes the epidemiology, clinical features, techniques for diagnosis, and drugs associated with treatment of this rare disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.